Ken Griffin acquired 3.25M Abbvie shares worth $689M. That's 0.59% of their equity portfolio (13th largest holding). The first Abbvie trade was made in Q2 2013. Since then Ken Griffin bought shares 62 more times and sold shares on 55 occasions. The stake costed the investor $612M, netting the investor a gain of 13% so far.